The Campaign for Sustainable Rx Pricing (CSRxP), of which the AHA is a founding member, today launched new television and digital advertising encouraging policymakers to hold brand name drug companies accountable. The ads, part of CSRxP’s Promises Made campaign, will target Washington, D.C. and 10 states, including Alaska, Arizona, Colorado, Delaware, Georgia, New Hampshire, New Jersey and West Virginia.

“Policymakers in Washington promised the American people action to lower prescription drug prices and hold Big Pharma accountable,” said CSRxP Executive Director Lauren Aronson. “The millions of Americans who cannot afford their medications as a result of Big Pharma’s egregious price hikes, that continued during the pandemic, are counting on promises made to become promises kept.”

 

Related News Articles

Headline
The median net launch price for 154 new drugs increased 51% between 2022 and 2024, after accounting for inflation and discounts, according to a report released…
Headline
President Trump today announced the first agreement with a major pharmaceutical company, Pfizer, to bring American drug prices in line with the lowest paid by…
Headline
The AHA Sept. 8 urged the Federal Trade Commission and Antitrust Division of the Department of Justice to investigate several drug companies’ concerted efforts…
Headline
The Department of Health and Human Services today announced prescription drug reforms that will become effective Oct. 1 originating from the Health Data,…
Headline
The Trump administration today announced steps drug manufacturers must take to lower prescription drug prices in the U.S. to "most favored nation" pricing, the…
Headline
The Department of Health and Human Services today issued a notice announcing a 340B Rebate Model Pilot Program as a voluntary mechanism for qualifying drug…